Freestone Capital Holdings’s Quest Diagnostics DGX Stock Holding History
Bought
Maintained
Sold
Other funds holding DGX
Freestone Capital Holdings's DGX Position: Q3 2022 in Review
Freestone Capital Holdings sold out of Quest Diagnostics (DGX) in Q3 2022, closing a stake of 1,656 shares — an estimated $220K sold.
Freestone Capital Holdings first reported a position in DGX in Q3 2015 and held it in 20 quarters. The position peaked at $3.64M in Q1 2019. 808 funds tracked by Wall St. Rank hold DGX as of Q3 2022.
- Freestone Capital Holdings reported no remaining Quest Diagnostics position as of Q3 2022 after selling out during the quarter.
- Freestone Capital Holdings sold 1,656 Quest Diagnostics shares in Q3 2022, an estimated $220K.
- Freestone Capital Holdings first reported a position in Quest Diagnostics in Q3 2015 and held it in 20 quarters.
- Freestone Capital Holdings's Quest Diagnostics position peaked at $3.64M in Q1 2019.
- 808 funds tracked by Wall St. Rank held Quest Diagnostics as of Q3 2022.
Based on Freestone Capital Holdings's 13F filing for Q3 2022, filed 9 Nov 2022.